Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
In the majority of cases, asthma and chronic obstructive pulmonary disease (COPD) are two clearly distinct disease entities. However, in some patients there may be significant overlap between the two conditions. This constitutes an important area of concern because these patients are generally exclu...
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Język: | English |
| Wydane: |
2014
|
| _version_ | 1826307274600087552 |
|---|---|
| author | Vanfleteren, L Kocks, J Stone, I Breyer-Kohansal, R Greulich, T Lacedonia, D Buhl, R Fabbri, L Pavord, I Barnes, N Wouters, E Agusti, A |
| author_facet | Vanfleteren, L Kocks, J Stone, I Breyer-Kohansal, R Greulich, T Lacedonia, D Buhl, R Fabbri, L Pavord, I Barnes, N Wouters, E Agusti, A |
| author_sort | Vanfleteren, L |
| collection | OXFORD |
| description | In the majority of cases, asthma and chronic obstructive pulmonary disease (COPD) are two clearly distinct disease entities. However, in some patients there may be significant overlap between the two conditions. This constitutes an important area of concern because these patients are generally excluded from randomised controlled trials (mostly because of smoking history in the case of asthma or because of significant bronchodilator reversibility in the case of COPD). As a result, their pathobiology, prognosis and response to therapy are largely unknown. This may lead to suboptimal management and can limit the development of more personalised therapeutic options. Emerging genetic and molecular information coupled with new bioinformatics capabilities provide novel information that can pave the way towards a new taxonomy of airway diseases. In this paper we question the current value of the terms 'asthma' and 'COPD' as still useful diagnostic labels; discuss the scientific and clinical progress made over the past few years towards unravelling the complexity of airway diseases, from the definition of clinical phenotypes and endotypes to a better understanding of cellular and molecular networks as key pathogenic elements of human diseases (so-called systems medicine); and summarise a number of ongoing studies with the potential to move the field towards a new taxonomy of airways diseases and, hopefully, a more personalised approach to medicine, in which the focus will shift from the current goal of treating diseases as best as possible to the so-called P4 medicine, a new type of medicine that is predictive, preventive, personalised and participatory. |
| first_indexed | 2024-03-07T07:00:27Z |
| format | Journal article |
| id | oxford-uuid:ff91b4d8-02c9-42f9-afc6-b0d14cefa4b5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:00:27Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:ff91b4d8-02c9-42f9-afc6-b0d14cefa4b52022-03-27T13:45:56ZMoving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ff91b4d8-02c9-42f9-afc6-b0d14cefa4b5EnglishSymplectic Elements at Oxford2014Vanfleteren, LKocks, JStone, IBreyer-Kohansal, RGreulich, TLacedonia, DBuhl, RFabbri, LPavord, IBarnes, NWouters, EAgusti, AIn the majority of cases, asthma and chronic obstructive pulmonary disease (COPD) are two clearly distinct disease entities. However, in some patients there may be significant overlap between the two conditions. This constitutes an important area of concern because these patients are generally excluded from randomised controlled trials (mostly because of smoking history in the case of asthma or because of significant bronchodilator reversibility in the case of COPD). As a result, their pathobiology, prognosis and response to therapy are largely unknown. This may lead to suboptimal management and can limit the development of more personalised therapeutic options. Emerging genetic and molecular information coupled with new bioinformatics capabilities provide novel information that can pave the way towards a new taxonomy of airway diseases. In this paper we question the current value of the terms 'asthma' and 'COPD' as still useful diagnostic labels; discuss the scientific and clinical progress made over the past few years towards unravelling the complexity of airway diseases, from the definition of clinical phenotypes and endotypes to a better understanding of cellular and molecular networks as key pathogenic elements of human diseases (so-called systems medicine); and summarise a number of ongoing studies with the potential to move the field towards a new taxonomy of airways diseases and, hopefully, a more personalised approach to medicine, in which the focus will shift from the current goal of treating diseases as best as possible to the so-called P4 medicine, a new type of medicine that is predictive, preventive, personalised and participatory. |
| spellingShingle | Vanfleteren, L Kocks, J Stone, I Breyer-Kohansal, R Greulich, T Lacedonia, D Buhl, R Fabbri, L Pavord, I Barnes, N Wouters, E Agusti, A Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title | Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title_full | Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title_fullStr | Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title_full_unstemmed | Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title_short | Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? |
| title_sort | moving from the oslerian paradigm to the post genomic era are asthma and copd outdated terms |
| work_keys_str_mv | AT vanfleterenl movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT kocksj movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT stonei movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT breyerkohansalr movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT greulicht movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT lacedoniad movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT buhlr movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT fabbril movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT pavordi movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT barnesn movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT wouterse movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms AT agustia movingfromtheoslerianparadigmtothepostgenomiceraareasthmaandcopdoutdatedterms |